Aria Changes Name to Ariosa Diagnostics; Completes Clinical Validation of Prenatal Trisomy Test | GenomeWeb

Aria Diagnostics said this week that it has changed its name to Ariosa Diagnostics "to further distinguish and differentiate itself from other companies and products."

The company also said it has completed a clinical validation study for its Harmony Prenatal Test, a non-invasive test for common fetal trisomies. The test analyzes cell-free fetal DNA from maternal blood using targeted sequencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.